Lv et al. reported that xanthohumol, an NRF2-activating compound, effectively suppressed the LPS-activated TXNIP/NLRP3 inflammasome and the NF-κB signaling pathway in acute lung injury [25]. This evidence concerns the gene NLRP3 and injury.